We previously reported that SHP2 is required for IL-6-induced EMT in breast cancer cells35, but whether SHP2 contributes to the proliferation of breast cancer cells, and the related mechanistic details, remained to be determined. This evidence concerns the gene PTPN11 and breast carcinoma.